Should Patients Be Evaluated for ADHD While Using ADHD Medication?

被引:0
|
作者
Lovett, Benjamin J. [1 ,5 ]
Nelson, Jason M. [2 ]
Jordan, Alexander H. [3 ,4 ]
机构
[1] Columbia Univ, Teachers Coll, Sch Psychol Program, New York, NY USA
[2] Univ Georgia, Regents Ctr Learning Disorders, Athens, GA USA
[3] McLean Hosp, Belmont, MA USA
[4] Harvard Med Sch, Dept Psychiat, Cambridge, MA USA
[5] Columbia Univ, Teachers Coll, Sch Psychol Program, Box 120,525 West 120th St, New York, NY 10027 USA
关键词
attention-deficit/hyperactivity disorder; diagnostic assessment; stimulant medication; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; OF-THE-LITERATURE; STIMULANT MEDICATION; EXTENDED-RELEASE; HYPERACTIVITY; METHYLPHENIDATE; CHILDREN; EFFICACY; WITHDRAWAL; PSYCHOSTIMULANTS;
D O I
10.1037/pro0000555
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Psychologists often perform evaluations on patients who are already being prescribed stimulant medication for attention-deficit/hyperactivity disorder. The evaluation may be sought to confirm the diagnosis or to determine specific treatment or accommodation needs. In these cases, psychologists are often asked whether the patient should take their medication as prescribed on the day of the evaluation. There does not appear to be any existing authoritative guidance on this question, and different clinics and clinicians have different policies. In the present article, relevant research on stimulant effects and attention-deficit/hyperactivity disorder assessment tools is reviewed, to develop empirically informed guidance for determining when patients should take their medication on evaluation day and when they should not. The article concludes with several proposed guidelines for practice, synthesizing findings from the available research with consideration of psychologists' ethical responsibilities.
引用
收藏
页码:160 / 168
页数:9
相关论文
共 50 条
  • [21] ADHD medication treatment and risk of psychosis
    Hechtman, Lily
    LANCET PSYCHIATRY, 2019, 6 (08): : 632 - 633
  • [22] European guidelines on managing adverse effects of medication for ADHD
    Graham, J.
    Banaschewski, T.
    Buitelaar, J.
    Coghill, D.
    Danckaerts, M.
    Dittmann, R. W.
    Doepfner, M.
    Hamilton, R.
    Hollis, C.
    Holtmann, M.
    Hulpke-Wette, M.
    Lecendreux, M.
    Rosenthal, E.
    Rothenberger, A.
    Santosh, P.
    Sergeant, J.
    Simonoff, E.
    Sonuga-Barke, E. J. S.
    Wong, I. C. K.
    Zuddas, A.
    Steinhausen, H. -C.
    Taylor, E.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2011, 20 (01) : 17 - 37
  • [23] The Impact of Stimulant Medication on the Relation Between Working Memory and Activity Level in ADHD
    Wiegers, Emily
    Garner, Annie
    Jusko, Morgan
    Smith, Jessica N.
    Campez, Mileini
    Greiner, Andrew
    Gnagy, Elizabeth
    Pelham, William E.
    Raiker Jr, Joseph
    RESEARCH ON CHILD AND ADOLESCENT PSYCHOPATHOLOGY, 2024, 52 (09): : 1357 - 1368
  • [24] A Customized Medication Adherence Enhancement Program for Adolescents and Young Adults With ADHD (CAE-ADHD): Primary Outcomes
    McVoy, Molly
    Abdallah, Salayna M.
    Church, Emma
    Yala, Joy
    Briggs, Farren
    Levin, Jennifer B.
    JOURNAL OF ATTENTION DISORDERS, 2025,
  • [25] Changes in use of psychostimulant medication for ADHD in South Australia (1990-2006)
    Prosser, Brenton
    Reid, Robert
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2009, 43 (04) : 340 - 347
  • [26] Improving Medication Adherence in Chronic Pediatric Health Conditions: A Focus on ADHD in Youth
    Chacko, Anil
    Newcorn, Jeffrey H.
    Feirsen, Nicole
    Uderman, Jodi Z.
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (22) : 2416 - 2423
  • [27] Cumulative exposure to ADHD medication is inversely related to hippocampus subregional volume in children
    Fotopoulos, Nellie H.
    Devenyi, Gabriel A.
    Guay, Stephanie
    Sengupta, Sarojini M.
    Chakravarty, M. Mallar
    Grizenko, Natalie
    Karama, Sherif
    Joober, Ridha
    NEUROIMAGE-CLINICAL, 2021, 31
  • [28] Using ADHD Medications to Treat Coexisting ADHD and Reading Disorders: A Systematic Review
    Froehlich, Tanya E.
    Fogler, Jason
    Barbaresi, William J.
    Elsayed, Nada A.
    Evans, Steven W.
    Chan, Eugenia
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (04) : 619 - 637
  • [29] Racial-Ethnic Differences in Patterns of Discontinuous Medication Treatment Among Medicaid-Insured Youths With ADHD
    Ji, Xu
    Druss, Benjamin G.
    Lally, Cathy
    Cummings, Janet R.
    PSYCHIATRIC SERVICES, 2018, 69 (03) : 322 - 331
  • [30] Accident Proneness in Children and Adolescents Affected by ADHD and the Impact of Medication
    Lange, Hannah
    Buse, Judith
    Bender, Stephan
    Siegert, Joachim
    Knopf, Hildtraud
    Roessner, Veit
    JOURNAL OF ATTENTION DISORDERS, 2016, 20 (06) : 501 - 509